INSP
Inspire Medical Systems, Inc.
Healthcare — Medical Devices
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Price History
Fundamentals
| Market Cap | $1.31B |
| P/E Ratio (TTM) | 10.33 |
| Forward P/E | 35.48 |
| EPS (TTM) | $4.40 |
| Dividend Yield | - |
| Profit Margin | 14.33% |
| Revenue Growth | 1.60% |
| ROE | 18.37% |
| Debt/Equity | 3.73 |
| Recommendation | Hold 2.7 |
| Analyst Target | $51.77 |
| Analysts | 13 |
| Next Earnings | Aug 3, 2026 AMC |
| Indexes | - |
Technical Indicators
| RSI (14) | 63.7 |
| Beta | 0.73 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $147.03 |
| 52-Week Low | $38.91 |
| 50-Day Avg | $45.30 |
| 200-Day Avg | $71.61 |
| Avg Volume | $1.17M |
| Volume | $1.06M |
Performance Analysis
NEUTRALINSP presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:15 UTC
Back to Screener Export Report